Glypican-3-specific CAR-NKT cells overexpressing BATF3 mediate potent antitumor activity against hepatocellular carcinoma.

Shaik, RS; Rathi, P; Courtney, A; Schneller, N; Guo, LJ; Barragan, G; Zhang, CC; Xu, X; Sumazin, P; Metelitsa, L; Heczey, A

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):